DALTILE HIGHLIGHTS 2024 NEW PRODUCT LAUNCHES — END OF YEAR RECAP
DALLAS, Dec. 27, 2024 /PRNewswire/ — In 2024, Daltile added new tile and stone collections into its industry-leading product line along with launches of extra-large porcelain and quartz slabs. Daltile is the nation’s largest manufacturer and marketer of tile, stone, and countertop produ
Common Accidents Which Can Lead To A Miami Personal Injury Lawsuit
MIAMI, Dec. 27, 2024 /PRNewswire/ — The Law Offices of Jason Turchin highlights some of the most common accidents that may result in a Miami personal injury lawsuit, helping victims understand their rights and options for seeking compensation. From car crashes to slip and fall injuries, person
Founder Shares Unforgettable Lessons After Spending $1 Million on a Domain Name
ATLANTA, Dec. 27, 2024 /PRNewswire/ — VPN.com CEO Michael Gargiulo recently shared invaluable insights with Entrepreneur on the unforgettable lessons he learned while spending $1 million to acquire the premium domain VPN.com. Gargiulo’s journey to acquiring VPN.com wasn’t just a
Discount Tire Acquires Desert Ridge Corporate Center in Phoenix
Leading Retailer Has Been Tenant at 12-acre Campus Since 2019 PHOENIX, Dec. 27, 2024 /PRNewswire/ — Discount Tire through its affiliated real estate division, Halle Properties, LLC, closed on the purchase of Desert Ridge Corporate Center I and II in Phoenix. Desert Ridge includes 275,208-squa
APLT INVESTOR DEADLINE: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO, Dec. 27, 2024 /PRNewswire/ — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, inclusive (the “Class Period”), have until Febr
INTERNATIONAL HOLOCAUST SURVIVORS NIGHT BRINGS CELEBRITIES AND DIGNITARIES OUT TO CELEBRATE HOLOCAUST SURVIVORS AROUND THE WORLD ON DECEMBER 29, 2024
This 8th Annual International Holocaust Survivors Night, The Claims Conference Brings Together Celebrities, Government Leaders And Dignitaries As Well As Fellow Survivors From More Than A Dozen Countries To Honor Holocaust Survivors Around The World. NEW YORK, Dec. 27, 2024 /PRNewswire/ — The
" title="“Intangible Cultural Heritage in China” Now Airing on CCTV
BEIJING, Dec. 27, 2024 /PRNewswire/ — Intangible Cultural Heritage in China, a landmark cultural series jointly presented by China Media Group (CMG) and the Ministry of Culture and Tourism of the People’s Republic of China, takes audiences on an immersive journey where tradition and inno
TUSK Practice Sales Celebrates a Transformative 2024 with Expansion, Recognition, and Charitable Impact
CHARLOTTE, N.C., Dec. 27, 2024 /PRNewswire/ — TUSK Practice Sales celebrates a transformative 2024 marked by growth, industry recognition, and a commitment to clients and the community. In 2024, TUSK expanded its services into three new industries, welcomed key team members, and strengthened i
Life Time Celebrates End of 2024 with Opening of Its Rosemount Athletic Country Club in Minnesota on December 27th
Company opened seven new destinations across six different states; Partnership with City of Rosemount brings seven pickleball courts, recovery amenities, cold plunge pools and more ROSEMOUNT, Minn., Dec. 27, 2024 /PRNewswire/ — Life Time (NYSE: LTH) today announced the Dec. 27 opening of its
YolTech Therapeutics Granted FDA Orphan Drug and Rare Pediatric Disease Designations for YOLT-203 to Treat Primary Hyperoxaluria Type 1
SHANGHAI, Sept. 4, 2024 /PRNewswire/ — YolTech Therapeutics, a clinical-stage in vivo gene editing company, announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) to YOLT-203 for the treatment of primary hyperoxaluria type 1 (PH1) in September. Earlier
